News Headlines Article

Panel’s report blames drug shortages on FDA regulation
Modern Healthcare

A new report from a Republican-led House oversight committee (PDF) has found that regulatory activity by the Food and Drug Administration at drug-company facilities has led to a shortage of generic, injectable medications.

According to the findings from the House Committee on Oversight and Government Reform, the FDA’s regulatory activity has shut down about 30% of total manufacturing capacity at four of the nation’s largest producers of injectible medications: